Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Alzheimer's Disease Diagnostic Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Early-onset Alzheimer's Market Performance (Volume)
  • 2.1.2 Late-onset Alzheimer's Market Performance (Volume)
  • 2.1.3 Familial Alzheimer's Disease Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Early-onset Alzheimer's Market Performance (Value)
  • 2.1.2 Late-onset Alzheimer's Market Performance (Value)
  • 2.1.3 Familial Alzheimer's Disease Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Clinics Market Performance (Volume)
  • 3.1.2 Hospitals Market Performance (Volume)
  • 3.1.3 Diagnostic Centers Market Performance (Volume)
  • 3.1.4 Others Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Eli Lilly and Company (UK)
  • 4.1.1 Eli Lilly and Company (UK) Profiles
  • 4.1.2 Eli Lilly and Company (UK) Product Information
  • 4.1.3 Eli Lilly and Company (UK) Alzheimer's Disease Diagnostic Business Performance
  • 4.1.4 Eli Lilly and Company (UK) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.2 TauRx (Republic of Singapore)
  • 4.2.1 TauRx (Republic of Singapore) Profiles
  • 4.2.2 TauRx (Republic of Singapore) Product Information
  • 4.2.3 TauRx (Republic of Singapore) Alzheimer's Disease Diagnostic Business Performance
  • 4.2.4 TauRx (Republic of Singapore) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.3 Alector LLC (US)
  • 4.3.1 Alector LLC (US) Profiles
  • 4.3.2 Alector LLC (US) Product Information
  • 4.3.3 Alector LLC (US) Alzheimer's Disease Diagnostic Business Performance
  • 4.3.4 Alector LLC (US) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.4 Accera (US)
  • 4.4.1 Accera (US) Profiles
  • 4.4.2 Accera (US) Product Information
  • 4.4.3 Accera (US) Alzheimer's Disease Diagnostic Business Performance
  • 4.4.4 Accera (US) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.5 Treventis Corporation (US)
  • 4.5.1 Treventis Corporation (US) Profiles
  • 4.5.2 Treventis Corporation (US) Product Information
  • 4.5.3 Treventis Corporation (US) Alzheimer's Disease Diagnostic Business Performance
  • 4.5.4 Treventis Corporation (US) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.6 Neuro-Bio Ltd (UK)
  • 4.6.1 Neuro-Bio Ltd (UK) Profiles
  • 4.6.2 Neuro-Bio Ltd (UK) Product Information
  • 4.6.3 Neuro-Bio Ltd (UK) Alzheimer's Disease Diagnostic Business Performance
  • 4.6.4 Neuro-Bio Ltd (UK) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.7 Cognition Therapeutics (US)
  • 4.7.1 Cognition Therapeutics (US) Profiles
  • 4.7.2 Cognition Therapeutics (US) Product Information
  • 4.7.3 Cognition Therapeutics (US) Alzheimer's Disease Diagnostic Business Performance
  • 4.7.4 Cognition Therapeutics (US) Alzheimer's Disease Diagnostic Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Europe Alzheimer's Disease Diagnostic Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Alzheimer's Disease Diagnostic Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Alzheimer's Disease Diagnostic Market Performance (Sales Point)

• 7.1 Europe Alzheimer's Disease Diagnostic Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Alzheimer's Disease Diagnostic Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Alzheimer's Disease Diagnostic Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Alzheimer's Disease Diagnostic Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Clinics Industry
• 11.2 Hospitals Industry
• 11.3 Diagnostic Centers Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Alzheimer's Disease Diagnostic Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Early-onset Alzheimer's Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Late-onset Alzheimer's Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Familial Alzheimer's Disease Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Clinics Sales and and Growth Rate 2019-2024
  • 12.4.3 Hospitals Sales and and Growth Rate 2019-2024
  • 12.4.4 Diagnostic Centers Sales and and Growth Rate 2019-2024
  • 12.4.5 Others Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Alzheimer's Disease Diagnostic Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Alzheimer's Disease Diagnostic Gross Profit Trend 2019-2024

13 Conclusion

Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Alzheimer's Disease Diagnostic for these regions, from 2012 to 2023 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain

Europe Alzheimer's Disease Diagnostic market competition by top manufacturers/players, with Alzheimer's Disease Diagnostic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Eli Lilly and Company (UK)
TauRx (Republic of Singapore)
Alector LLC (US)
Accera (US)
Treventis Corporation (US)
Neuro-Bio Ltd (UK)
Cognition Therapeutics (US)
...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Early-onset Alzheimer's
Late-onset Alzheimer's
Familial Alzheimer's Disease

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Alzheimer's Disease Diagnostic for each application, including
Clinics
Hospitals
Diagnostic Centers
Others

If you have any special requirements, please let us know and we will offer you the report as you want.